DF/HCC Program Affiliation

Breast Cancer

Research Abstract

Research interests include therapies for early-stage and advanced breast cancer, including neoadjuvant treatments, concurrent radiotherapy/chemotherapy and biological therapies. In addition, I am intrested in use of alternative medicine by women with breast cancer, health care for breast cancer surviors, and quality of life and physhosocial issues among wmoen with histories of breast cancer.

Publications

• Burstein HJ.Anemia in cancer: update on studies of erythropoiesis-stimulating agents.J Support Oncol 2007 Apr;5(4 Suppl 2):5-26.
  17550053
• Miller KD, Sledge GW, Burstein HJ.Angiogenesis inhibition in the treatment of breast cancer: a review of studies presented at the 2006 san antonio breast cancer symposium.Clin Adv Hematol Oncol 2007 Mar;5(3):1-12.
  17519886
• Burstein HJ.Biological basis of breast cancer: an introduction.Semin Oncol 2007 Apr;34(2 Suppl 3):S1-3.
  17512430
• Mayer EL, Burstein HJ.Chemotherapy for metastatic breast cancer.Hematol Oncol Clin North Am 2007 Apr;21(2):257-72.
  17512448
• Podoloff DA, Advani RH, Allred C, Benson AB 3rd, Brown E, Burstein HJ, Carlson RW, Coleman RE, Czuczman MS, Delbeke D, Edge SB, Ettinger DS, Grannis FW Jr, Hillner BE, Hoffman JM, Kiel K, Komaki R, Larson SM, Mankoff DA, Rosenzweig KE, Skibber JM, Yahalom
  17509259
• Carlson RW, Anderson BO, Burstein HJ, Carter WB, Edge SB, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Ljung BM, Kiel K, Marks LB, McCormick B, Nabell LM, Pierce LJ, Reed EC, Silver SM, Smith ML, Somlo G, Theriault RL, Ward JH, W
  17439758
• Mayer EL, Lin NU, Burstein HJ.Novel approaches to advanced breast cancer: bevacizumab and lapatinib.J Natl Compr Canc Netw 2007 Mar;5(3):314-23.
  17439759
• Burstein HJ.Myeloid growth factor support for dose-dense adjuvant chemotherapy for breast cancer.Oncology (Huntingt) 2006 Dec;20(14 Suppl 9):13-5.
  17370924
• Harris LN, You F, Schnitt SJ, Witkiewicz A, Lu X, Sgroi D, Ryan PD, Come SE, Burstein HJ, Lesnikoski BA, Kamma M, Friedman PN, Gelman R, Iglehart JD, Winer EP.Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early bre
  17317830
• Sledge GW, Rugo HS, Burstein HJ.The role of angiogenesis inhibition in the treatment of breast cancer.Clin Adv Hematol Oncol 2006 Oct;4 Suppl 21(10):1-12.
  17139244
• Tolaney SM, Partridge AH, Sheib RG, Burstein HJ, Winer EP.Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer.J Clin Oncol 2006 Nov 20;24(33):5330-1.
  17114668
• Burstein HJ, Overmoyer B, Gelman R, Silverman P, Savoie J, Clarke K, Dumadag L, Younger J, Ivy P, Winer EP.Rebeccamycin analog for refractory breast cancer: a randomized phase II trial of dosing schedules.Invest New Drugs 2007 Apr;25(2):161-4.
  16969707
• Carlson RW, Moench SJ, Hammond ME, Perez EA, Burstein HJ, Allred DC, Vogel CL, Goldstein LJ, Somlo G, Gradishar WJ, Hudis CA, Jahanzeb M, Stark A, Wolff AC, Press MF, Winer EP, Paik S, Ljung BM,.HER2 testing in breast cancer: NCCN Task Force report and re
  16813731
• Punglia RS, Kuntz KM, Winer EP, Weeks JC, Burstein HJ.The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.Cancer 2006 Jun 15;106(12):2576-82
  16703595
• Carlson RW, Brown E, Burstein HJ, Gradishar WJ, Hudis CA, Loprinzi C, Mamounas EP, Perez EA, Pritchard K, Ravdin P, Recht A, Somlo G, Theriault RL, Winer EP, Wolff AC,.NCCN Task Force Report: Adjuvant Therapy for Breast Cancer.J Natl Compr Canc Netw 2006
  16507275
• Peppercorn J, Partridge A, Burstein HJ, Winer EP.Standards for follow-up care of patents with breast cancer.Breast 2005 Dec;14(6):500-8.
  16288876
• Burstein HJ, Bellon JR, Galper S, Lu HM, Kuter I, Taghian AG, Wong J, Gelman R, Bunnell CA, Parker LM, Garber JE, Winer EP, Harris JR, Powell SN.Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophos
  16243442
• Burstein HJ, Manola J, Younger J, Parker LM, Bunnell CA, Scheib R, Matulonis UA, Garber JE, Clarke KD, Shulman LN, Winer EP.Docetaxel administered on a weekly basis for metastatic breast cancer.J Clin Oncol 2000 Mar;18(6):1212-9.
  10715290
• Burstein HJ, Gelber S, Guadagnoli E, Weeks JC.Use of alternative medicine by women with early-stage breast cancer.N Engl J Med 1999 Jun 3;340(22):1733-9.
  10352166